Bemarituzumab Biosimilar (FGFR2 / CD332 Reference Antibody)
Bemarituzumab is a first-in-class, humanized IgG1 monoclonal antibody against FGFR2b (a FGF receptor) . Bemarituzumab blocks fibroblast growth factors from binding and activating FGFR2b. Bemarituzumab has the potential for cancer research.
Product Specifications
Target
Bemarituzumab Biosimilar (Anti-FGFR2 / CD332 Reference Antibody)
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Immunology & Inflammation; Cell Biology
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
VAng-Cr1840-500gEcoli 500 µg (E. coli)
Recombinant Yersinia Enterocolitica fabZ Protein (aa 1-168)
Sign In for Pricing
View Details LV676287 1.0 µg DNA
BTLA Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-GFP-2A-Puro)
Sign In for Pricing
View Details K2016706 1.0 µg DNA
RPS6P18 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 1)
Sign In for Pricing
View Details 
MBS6424309-01 0.1 mL
KRT8 (Cytokeratin 8, Keratin 8, CARD2, CK8, CYK8, K2C8, K8, KO) (Biotin)
Sign In for Pricing
View Details MBS6424309-02 5x 0.1 mL
KRT8 (Cytokeratin 8, Keratin 8, CARD2, CK8, CYK8, K2C8, K8, KO) (Biotin)
Sign In for Pricing
View Details